These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23769325)

  • 1. Improved quality of life over one year is associated with improved adherence in patients with schizophrenia.
    Hayhurst KP; Drake RJ; Massie JA; Dunn G; Barnes TR; Jones PB; Lewis SW
    Eur Psychiatry; 2014 Mar; 29(3):191-6. PubMed ID: 23769325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia.
    Wehmeier PM; Kluge M; Schacht A; Helsberg K; Schreiber W; Schimmelmann BG; Lambert M
    J Psychiatr Res; 2008 Jul; 42(8):676-83. PubMed ID: 17720192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with adherence to treatment with olanzapine and other atypical antipsychotic medications in patients with schizophrenia.
    Liu-Seifert H; Osuntokun OO; Feldman PD
    Compr Psychiatry; 2012 Jan; 53(1):107-15. PubMed ID: 21310400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CATIE and CUtLASS studies in schizophrenia: results and implications for clinicians.
    Naber D; Lambert M
    CNS Drugs; 2009 Aug; 23(8):649-59. PubMed ID: 19594194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of subjective versus objective quality of life assessment in people with schizophrenia.
    Hayhurst KP; Massie JA; Dunn G; Lewis SW; Drake RJ
    BMC Psychiatry; 2014 Dec; 14():365. PubMed ID: 25539658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone.
    Phillips GA; Van Brunt DL; Roychowdhury SM; Xu W; Naber D
    J Clin Psychiatry; 2006 Sep; 67(9):1397-403. PubMed ID: 17017826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between depressive symptoms and quality of life in Nigerian patients with schizophrenia.
    Akinsulore A; Aloba OO; Mapayi BM; Oloniniyi IO; Fatoye FO; Makanjuola RO
    Soc Psychiatry Psychiatr Epidemiol; 2014 Aug; 49(8):1191-8. PubMed ID: 24549838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes.
    Dunayevich E; Sethuraman G; Enerson M; Taylor CC; Lin D
    Schizophr Res; 2006 Sep; 86(1-3):300-8. PubMed ID: 16860974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?
    Tollefson GD; Andersen SW
    J Clin Psychiatry; 1999; 60 Suppl 5():23-9; discussion 30. PubMed ID: 10192404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial.
    Revicki DA; Genduso LA; Hamilton SH; Ganoczy D; Beasley CM
    Qual Life Res; 1999 Aug; 8(5):417-26. PubMed ID: 10474283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socio-demographic and clinical determinants of quality of life in Chinese patients with schizophrenia: a prospective study.
    Xiang YT; Wang CY; Wang Y; Chiu HF; Zhao JP; Chen Q; Chan SS; Lee EH; Ungvari GS
    Qual Life Res; 2010 Apr; 19(3):317-22. PubMed ID: 20135234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia.
    Aki H; Tomotake M; Kaneda Y; Iga J; Kinouchi S; Shibuya-Tayoshi S; Tayoshi SY; Motoki I; Moriguchi K; Sumitani S; Yamauchi K; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Res; 2008 Feb; 158(1):19-25. PubMed ID: 18160137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia.
    Vassileva I; Milanova V; Asan T
    Community Ment Health J; 2014 Oct; 50(7):854-61. PubMed ID: 24452824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality of life in patients with schizophrenia: a study of 100 cases].
    Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
    Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life of Chinese schizophrenia outpatients in Hong Kong: relationship to sociodemographic factors and symptomatology.
    Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
    Aust N Z J Psychiatry; 2007 May; 41(5):442-9. PubMed ID: 17464737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Socio-demographic and clinical correlates of subjective quality of life among Nigerian outpatients with schizophrenia.
    Adelufosi AO; Ogunwale A; Abayomi O; Mosanya JT
    Psychiatry Res; 2013 Oct; 209(3):320-5. PubMed ID: 23452754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.